| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |